|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,840 KRW | +0.88% |
|
+1.18% | -7.94% |
Kwang Dong Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 8,766.4 million compared to KRW 5,197.57 million a year ago. Net income was KRW 36,965.56 million compared to KRW 24,173.93 million a year ago.
Basic earnings per share from continuing operations was KRW 913 compared to KRW 588 a year ago. Basic earnings per share was KRW 913 compared to KRW 588 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.94% | 199M | |
| +20.37% | 43.75B | |
| +27.47% | 22.06B | |
| +13.30% | 14.46B | |
| +13.03% | 13.62B | |
| +38.31% | 11.61B | |
| -9.54% | 6.9B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +9.64% | 5.32B |
KWANG DONG PHARMACEUTICAL CO., LTD. 
